Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study
- PMID: 9048514
- DOI: 10.1093/oxfordjournals.aje.a009122
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study
Abstract
The authors ascertained cardiovascular events (myocardial infarction and angina pectoris) in 498 women with systemic lupus erythematosus seen at the University of Pittsburgh Medical Center from 1980 to 1993 (3,522 person-years). Subjects were stratified by age, and cardiovascular event incidence rates were determined. The authors compared these rates with cardiovascular event rates were determined. The authors compared these rates with cardiovascular event rates occurring over the same time period in 2,208 women of similar age participating in the Framingham Offspring Study (17,519 person-years). Age-specific rate ratios were computed to determine whether the cardiovascular events in the lupus cohort were greater than expected. The risk factors associated with cardiovascular events in women with lupus were determined. There were 33 first events (11 myocardial infarction, 10 angina pectoris, and 12 both angina pectoris and myocardial infarction) after the diagnosis of lupus: two thirds were under the age of 55 years at the time of event. Women with lupus in the 35- to 44-year age group were over 50 times more likely to have a myocardial infarction than were women of similar age in the Framingham Offspring Study (rate ratio = 52.43, 95% confidence interval 21.6-98.5). Older age at lupus diagnosis, longer lupus disease duration, longer duration of corticosteroid use, hypercholesterolemia, and postmenopausal status were more common in the women with lupus who had a cardiovascular event than in those who did not have an event. Premature cardiovascular disease is much more common in young premenopausal women with lupus than in a population sample. With the increased life expectancy of lupus patients due to improved therapy, cardiovascular disease has emerged as a significant threat to the health of these women. The impact of this problem has been underrecognized, with little focus placed on aggressive management of hypercholesterolemia and other possible risk factors.
Similar articles
-
Major adverse cardiovascular events and mortality in systemic lupus erythematosus patients after successful delivery: a population-based study.Am J Med Sci. 2014 Jan;347(1):42-9. doi: 10.1097/MAJ.0b013e318278707f. Am J Med Sci. 2014. PMID: 23255242
-
Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea.Lupus. 2018 Nov;27(13):2050-2056. doi: 10.1177/0961203318804883. Epub 2018 Oct 3. Lupus. 2018. PMID: 30282562
-
Is systemic lupus erithematosus a new risk factor for atherosclerosis?Arq Bras Cardiol. 2006 Sep;87(3):300-6. doi: 10.1590/s0066-782x2006001600012. Arq Bras Cardiol. 2006. PMID: 17057930 English, Portuguese.
-
Myocardial Infarction in Systemic Lupus Erythematosus - the Sex-Specific Risk Profile.Curr Pharm Des. 2021;27(29):3221-3228. doi: 10.2174/1381612826666201210110809. Curr Pharm Des. 2021. PMID: 33302858 Review.
-
[Atherosclerosis in systemic lupus erythematosus].Presse Med. 2014 Oct;43(10 Pt 1):1034-47. doi: 10.1016/j.lpm.2014.01.021. Epub 2014 Sep 5. Presse Med. 2014. PMID: 25201598 Review. French.
Cited by
-
Effect of Spermidine on Endothelial Function in Systemic Lupus Erythematosus Mice.Int J Mol Sci. 2024 Sep 14;25(18):9920. doi: 10.3390/ijms25189920. Int J Mol Sci. 2024. PMID: 39337408 Free PMC article.
-
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus.Arthritis Res Ther. 2024 Sep 14;26(1):160. doi: 10.1186/s13075-024-03395-6. Arthritis Res Ther. 2024. PMID: 39272198 Free PMC article.
-
Beneficial effects of rapamycin on endothelial function in systemic lupus erythematosus.Front Physiol. 2024 Aug 21;15:1446836. doi: 10.3389/fphys.2024.1446836. eCollection 2024. Front Physiol. 2024. PMID: 39234308 Free PMC article.
-
The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis.Hum Vaccin Immunother. 2024 Dec 31;20(1):2387461. doi: 10.1080/21645515.2024.2387461. Epub 2024 Aug 16. Hum Vaccin Immunother. 2024. PMID: 39149877 Free PMC article. Review.
-
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.MMWR Recomm Rep. 2024 Aug 8;73(4):1-126. doi: 10.15585/mmwr.rr7304a1. MMWR Recomm Rep. 2024. PMID: 39106314 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical